Home › Stocks › JNJ vs PFE
JNJ
Johnson & Johnson
$244.44
vs
PFE
Pfizer Inc.
$28.08

Head-to-Head Comparison

MetricJNJPFE
Market Cap$589.1B$159.7B
P/E Ratio16.010.0
Div YieldN/AN/A
SectorHealthcareHealthcare
Beta0.330.41
RevenueN/AN/A
Net IncomeN/AN/A
EPSN/AN/A

AI Comparison Brief

AI Generated
Verdict
Johnson & Johnson (JNJ) is the better investment right now due to its robust market capitalization of $589.08B, indicating a strong competitive position in the healthcare sector. With a lower beta of 0.326, JNJ presents a more stable investment compared to Pfizer (PFE), which has a higher beta of 0.412 suggesting greater volatility. Although both companies currently show N/A for P/E and EPS, JNJ's market presence and lower risk profile favor its growth trajectory, making it a more attractive option for conservative investors.
Key Differences
  • Market Capitalization: JNJ's market cap of $589.08B significantly surpasses PFE's $159.67B, reflecting greater investor confidence and market stability.
  • Volatility: JNJ's beta of 0.326 indicates lower volatility compared to PFE's beta of 0.412, making JNJ a safer choice for risk-averse investors.
  • Competitive Position: JNJ operates in a diversified healthcare sector with a strong brand portfolio, while PFE is primarily known for its pharmaceuticals, which could expose it to more market risk.
  • Growth Potential: JNJ may offer more consistent growth prospects due to its diversified revenue streams, whereas PFE's reliance on specific products could lead to fluctuations in growth rates.
Bottom Line
Investors seeking stability and less risk should consider Johnson & Johnson, while those willing to take on more volatility for potentially higher returns might look at Pfizer. Overall, JNJ is positioned as the safer bet in the current market landscape.
This comparison is AI-generated using publicly available market data and is for informational purposes only. It does not constitute investment advice. Always conduct your own research before making investment decisions.
Analysis generated 2026-04-15

Price Chart — JNJ vs PFE

Loading chart...
→ Johnson & Johnson (JNJ) Full Analysis → Pfizer Inc. (PFE) Full Analysis ← Stock Screener
Disclaimer: Stock data sourced from Financial Modeling Prep, updated daily. Prices may be delayed. Interactive charts powered by TradingView. This page is for informational and educational purposes only and does not constitute investment advice. We are not licensed financial advisors. Please consult a qualified professional before making investment decisions.

Privacy Policy · Terms